Prevalence and Predictors of Cisplatin-Induced Peripheral Neuropathy at the Kenyatta National Hospital
PURPOSE: To determine the prevalence, predictors, and/or risk factors of chemotherapy-induced peripheral neuropathy in patients undergoing chemotherapy with cisplatin at Kenyatta National Hospital, Nairobi, Kenya. METHODS: This was a cross-sectional analysis of patients who underwent chemotherapy wi...
Main Authors: | Mohammed S. Ezzi, Nicholas A. Othieno-Abinya, Erastus Amayo, Peter Oyiro, Angela McLigeyo, Robert Bett Yatich, Bonginkosi Shoba |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2019-09-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.19.00097 |
Similar Items
-
Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study
by: Angela McLigeyo, et al.
Published: (2022-02-01) -
Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy
by: Donertas B, et al.
Published: (2018-06-01) -
Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects
by: Edmone Dewaeles, et al.
Published: (2022-11-01) -
Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
by: Xindi Zhang, et al.
Published: (2022-07-01) -
The Pattern of Breast Diseases at Kenyatta National Hospital
by: E.S. Otieno, et al.
Published: (2008-06-01)